ATOS·04962H506·US·equity·Healthcare - Biotechnology-13D/G
ATOS (ATOSSA THERAPEUTICS INC) is held by 45 institutional investors as of Q4 2025. Largest holders: VANGUARD GROUP INC ($3.6M), AMERIPRISE FINANCIAL INC ($2.2M), RENAISSANCE TECHNOLOGIES LLC ($1.2M). Net institutional sentiment: Bullish.
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer